Thu.Feb 27, 2025

article thumbnail

Imaging discovery could accelerate drug development

European Pharmaceutical Review

Researchers at Pohang University of Science and Technology (POSTECH), South Korea, have developed a super-photostable organic dye. The discovery sets a new benchmark for organic fluorophores, Professor Young-Tae Chang explained, providing potential applications in broad areas such as drug development and cellular imaging. Single-molecule imaging uses fluorescent markers to track proteins with precision.

article thumbnail

Pharma Digital Marketing: Strategies to Boost Engagement and Drive ROI for Pharma Brands

Pharma Marketing Network

Introduction In todays fast-paced world, pharma digital marketing is more than just a strategyit’s a necessity. With increasing competition, strict regulations, and changing consumer behavior, pharmaceutical brands must embrace digital transformation to stay relevant. But how can pharma marketers break through the noise, engage their audience, and see real ROI?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: New kids on the block: A new generation of VCs ventures into biotech

STAT

Biotech venture capital is on the precipice of a generational shift. At least, that’s according to the crowd of younger firm founders edging their way in. There’s long been a small batch of scientists and business leaders who invest in drug companies. For the first 15 years of the 21st century, you’d find only 400, maybe 450 VC firms regularly giving money to drug startups — biotech’s own version of The Four Hundred , with lab coats or branded polar fleece, rat

article thumbnail

ACI’s 43rd FDA Boot Camp – New York City Edition

The FDA Law Blog

The American Conference Institutes popular FDA Boot Camp now in its 43rd iteration is scheduled to take place from March 19-20, 2025, at the NY Bar Association in New York, NY. The conference is billed as the premier event to provide folks with a roadmap to navigate the difficult terrain of FDA regulatory law. And it is exactly that! The conference equips legal professionals without prior regulatory experience, as well as life sciences executives involved with FDA-regulated products, with a

FDA
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

On measles outbreak, the Trump administration’s messaging strikes some as off-key

STAT

In 2019, amid a measles outbreak in New York, federal health officials uniformly preached the power of immunizations.  “Measles is preventable and the way to end this outbreak is to ensure that all children and adults who can get vaccinated, do get vaccinated,” said Robert Redfield , then the director of the Centers for Disease Control and Prevention.

article thumbnail

The ICH E6(R3) Guideline: A Major Update to Good Clinical Practice

The FDA Law Blog

By Julie Kim & Deborah L. Livornese As anticipated, the International Council for Harmonization (ICH) published the Good Clinical Practice (GCP) guideline E6(R3) Principles and Annex 1 on January 6, 2025. While ICH E6(R3) was still in the development phase, the FDA released a draft guidance in May 2023 in the form of the draft ICH E6(R3). No word yet on whether FDA will issue guidance endorsing the final ICH E6(R3).

More Trending

article thumbnail

The Current, Future Roles of AI within the Pharmacy Profession

Drug Topics

As artificial intelligence evolves from a novel technology to commonplace in health care, the pharmacy industry is adapting to its challenges and opportunities.

article thumbnail

STAT+: Federal government officials drop out of HIMSS health information conference

STAT

Federal health officials due to speak at the Healthcare Information and Management Systems Society meeting in Las Vegas next week have dropped out of the key health tech industry conference. Even as the Trump administration focuses on fraud, waste, and abuse, government officials aren’t allowed to tell the public about their programs aimed at preventing fraud, waste, and misuse in Medicare telehealth and remote patient monitoring programs.

article thumbnail

Significant Gaps Identified in Access to OTC Naloxone, Nonprescription Syringes

Drug Topics

Researchers conducted a cross-sectional study to investigate the accessibility of over-the-counter naloxone and nonprescription syringes at community pharmacies.

article thumbnail

STAT+: How to eliminate biotech zombies: Buy them

STAT

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. Health care investor Kevin Tang buys “zombie” biotechs to shut them down. It’s a counterintuitive, but ingenious solution to the sector’s intractable problem  covered in last week’s newsletter.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Eli Lilly Launches Self-Pay Vials of Tirzepatide for Patients With Obesity

Drug Topics

The announcement comes after the FDA declared the shortage of semaglutide (Ozempic, Wegovy) has been resolved after being in shortage since March 2022.

FDA
article thumbnail

STAT+: Pfizer revises its DEI webpage to emphasize importance of ‘merit’

STAT

Pfizer on Thursday made significant changes to its diversity, equity, and inclusion webpage , as companies across different industries seek to reposition their policies and messaging amid President Trump’s dismantling of DEI initiatives. The pharma company now emphasizes merit throughout its webpage. Pfizer has changed the title of the page from “Diversity, Equity, and Inclusion” to “Merit-Based Diversity, Equity, and Inclusion,” and added a sentence to its int

article thumbnail

Glycemic Control Among Patients With Diabetes Worsened Over Past Decade

Drug Topics

Authors of a research letter published in JAMA said that the decrease in glycemic control may be due to consequences of the COVID-19 pandemic, such as sedentary behavior and increased mental health stressors.

article thumbnail

AI deals are surging, and Recursion’s ongoing Exscientia merger points to a new world of integration

PharmaVoice

Recursion CFO Ben Taylor discusses the state of AI M&A and what companies should look for as the industry moves to new data technologies and systems.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

The gendered divide in physician mental health data

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Can you believe the temperature in Boston hit the 50s yesterday? It’s the first false start to spring, and I’m sure that there are more cold days ahead of us. But still, it was so, so sweet.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

A new report by nonprofit Phyx Primary Care finds that physicians feel more satisfied with their work and less burned out when supported by an ambient AI scribe.

article thumbnail

Vaccine sector on edge as HHS cancels flu meeting

pharmaphorum

An FDA advisory committee due to be held in March to discuss the formulation of influenza vaccines for the 2025/26 flu season has been cancelled.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Congress is poised to approve steep cuts to the Medicaid program, and multiple new studies seek to analyze the impact that significant changes could have on states and enrollees.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Phase 3 Data Offer Hope to Patients With Meniere Disease

Pharmacy Times

SPI-1005, a novel anti-inflammatory compound, achieved coprimary end points for efficacy, including improvements in hearing loss and speech discrimination.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

A rumored private equity buyout of Walgreens could lead the company to be split up, according to media reports. | A rumored private equity buyout of Walgreens could lead the company to be split up, according to media reports.

article thumbnail

FDA Ends Semaglutide Shortage Listing, Contributing to Ongoing Legal Challenges

Pharmacy Times

Pharmacies could still experience localized availability issues for semaglutide despite its removal from the drug shortage list.

FDA
article thumbnail

Kyorin partners Hyfe to develop DTx for chronic cough

pharmaphorum

Kyorin Pharma has signed a deal with Hyfe to develop a digital therapeutic (DTx) for people with chronic cough and launch it in Japan.

article thumbnail

High Ratio of Non-HDL Cholesterol to HDL Cholesterol Associated With Heightened Hypertension, Heart Disease Risk

Pharmacy Times

Compared with other indicators of cardiovascular risk, the ratio of non-high-density lipoprotein cholesterol (HDL-C) to normal HDL-C had a stronger association with the risk of hypertension and heart disease.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Athenahealth will offer Abridge's ambient clinical documentation solution as part of its growing suite of artificial intelligence tools for small and independent provider practices. | Abridge will join Suki and iScribe in athenahealth's suite of ambient AI tools for clinical documentation.

article thumbnail

Study Finds Radon Exposure Increases Odds of Gestational Diabetes

Pharmacy Times

Radon exposure during pregnancy was significantly linked to increased odds of gestational diabetes.

article thumbnail

Driving innovation in rare diseases: Digital health and collaboration

pharmaphorum

Discover how digital health technologies and collaboration are driving innovation in the field of rare diseases. Learn more about the latest advancements and how they are improving patient outcomes and access to care.

article thumbnail

GSK boss Emma Walmsley could see pay rise to nearly £22m this year

The Guardian - Pharmaceutical Industry

UK pharmaceutical companies aim to put executive pay on par with US rivals but package will depend on share price Business live latest updates GSKs chief executive could take home nearly 22m this year as the pharmaceutical company attempts to offer US-style pay packets to top executives. Emma Walmsleys pay package will reach a maximum of 21.56m if the companys share price rises by 50%, according to its annual report.

article thumbnail

Pfizer’s bet on gene therapies in haemophilia has been a bust

Pharmaceutical Technology

Pfizer has ended the global commercialisation of its haemophilia B (factor IX deficiency) gene therapy Beqvez, citing soft demand for gene therapies among haemophilia patients and physicians.

article thumbnail

CVS Pharmacy® introduces enhanced flu testing and treatment offerings

Pharmacy Times

As flu cases continue to remain high, select CVS pharmacies across 37 states launch combo test for Flu A, Flu B and COVID-19

article thumbnail

Eli Lilly to expand US pharma manufacturing with four new sites

Pharmaceutical Technology

Eli Lilly has announced plans to expand its domestic medicine production in the US with four new pharmaceutical manufacturing sites.

article thumbnail

Navigating Triple-Negative Breast Cancer Treatment With Sacituzumab Govitecan

Pharmacy Times

Sacituzumab govitecan improves outcomes but requires careful management of adverse effects.

article thumbnail

Regeneron tries again with lymphoma bispecific in US

pharmaphorum

Regeneron has refiled its CD20xCD3 bispecific odronextamab for lymphoma with the FDA, which was rejected last year, but is seeking a narrower label.

article thumbnail

Fostering Open Discussions With Women About Menopausal Symptoms

Pharmacy Times

Panelists explain how health care professionals evaluate menopause symptoms using validated questionnaires, symptom tracking, clinical interviews, hormonal tests, and patient-reported outcome measures to comprehensively assess severity and quality-of-life impact.